查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
心律管理设备市场 - 按产品（心律调节器、去颤器、体外去颤器、心臟再同步治疗设备），按应用、最终用途和预测，2023 - 2032 年
市场调查报告书
商品编码
1399750

心律管理设备市场 - 按产品（心律调节器、去颤器、体外去颤器、心臟再同步治疗设备），按应用、最终用途和预测，2023 - 2032 年

Cardiac Rhythm Management Devices Market - By Product (Pacemakers, Defibrillators, External Defibrillator, Cardiac Resynchronization Therapy Devices), By Application, End-use & Forecast, 2023 - 2032
出版日期: | 出版商: Global Market Insights Inc. | 英文 350 Pages | 商品交期: 2-3个工作天内

价格
简介目录

在全球老化的推动下，心律管理设备市场占有率预计在 2023 年至 2032 年间将以超过 6.2% 的CAGR成长。为了解决与年龄相关的心臟问题，对起搏器和植入式心律转復除颤器 (ICD) 等心律管理设备的需求不断增加。例如，根据 CDC 的数据，2021 年，美国约有 695,000 人死于心臟病，即每 5 名死亡人数中就有 1 人死于心臟病。

持续的研发工作导致了更复杂、更有效的设备的推出，改善了患者的治疗效果并鼓励医疗保健提供者采用这些设备。智慧技术、远端监控能力和设备小型化的整合将进一步促进行业前景。

整个心律管理设备产业根据产品、应用、最终用途和地区进行划分。

由于体外去颤器在解决心臟骤停方面发挥着至关重要的作用，其预计将在 2023 年和 2032 年显着增长。随着人们越来越认识到在危及生命的情况下及时干预的重要性，体外除颤器变得越来越容易使用且用户友好。这些设备在公共设施中的广泛使用，加上促进心肺復苏术和除颤器培训的倡议，正在增强医疗保健专业人员和非专业人士的能力。

根据最终用途范围，在全面的诊断和治疗服务的支持下，心臟护理中心细分市场将在 2023 年至 2032 年期间为市场带来可观的收入。这些中心拥有的专业知识和先进的医疗技术提供有效和专业的护理，鼓励心律管理设备作为治疗计划的基本要素。这些中心通常作为医学研究和创新的中心。他们对临床试验的参与以及尖端技术的整合将进一步推动产品需求。

受预防性医疗保健偏好的推动，亚太地区心律管理设备市场预计到 2032 年将出现显着增长，从而增加对心臟疾病的筛检和早期发现。该地区充满活力的经济发展导致医疗保健意识的提高，从而提高了个人投资先进心臟护理技术的意愿。医疗基础设施的持续扩张将在未来几年继续影响亚太地区的市场动态。

目录

第 1 章：方法与范围

第 2 章：执行摘要

第 3 章：心律管理设备产业洞察

  • 产业生态系统分析
  • 产业影响力
    • 成长动力
      • 心臟衰竭和其他心臟疾病的盛行率不断上升
      • 心律监测的技术进步和创新设备的引入
      • 提高大众意识
      • 久坐生活方式的兴起
      • 有利的报销方案
      • 老年人口基数不断增加，肥胖盛行率不断上升
    • 产业陷阱与挑战
      • 设备成本高
      • 产品召回
      • 严格的监管审批
  • 成长潜力分析
  • COVID-19 影响分析
  • 监管环境
    • 我们
    • 欧洲
  • 报销场景
  • 技术景观
  • 未来市场趋势
  • 2022 年定价分析
  • 管道产品
  • 指示景观
  • 启动场景
  • 起搏器数量，2018年-2032年
  • 除颤器数量，2018年-2032年
  • 2018年-2032年CRT设备台数
  • 波特的分析
  • 缺口分析
  • PESTEL分析

第 4 章：竞争格局

  • 介绍
  • 公司矩阵分析
  • 公司市占率分析
  • 竞争定位矩阵
  • 供应商矩阵分析
  • 战略仪表板

第 5 章：心律管理设备市场规模与预测：依产品

  • 关键科技趋势
  • 起搏器
    • 植入式心律调节器
    • 体外心律调节器
  • 除颤器
    • 植入式心臟復律去颤器 (ICD)
      • 经静脉植入式心臟復律去颤器
        • 单腔 ICD
        • 双腔 ICD
    • 体外去颤器
      • 手动体外心臟去颤器
      • 自动体外心臟去颤器
        • 半自动体外心臟去颤器
        • 全自动体外心臟去颤器
      • 穿戴式心臟復律去颤器
  • 心臟再同步治疗装置
    • 心臟再同步治疗装置-D
    • 心臟再同步治疗装置- P

第 6 章：心律管理设备市场规模与预测：按应用

  • 主要应用趋势
  • 充血性心臟衰竭
  • 心律不整
  • 心搏过缓
  • 心跳过速
  • 其他的

第 7 章：心律管理设备市场规模与预测：依最终用途

  • 主要最终用途趋势
  • 医院
  • 心臟护理中心
  • 门诊手术中心
  • 其他的

第 8 章：心律管理设备市场规模与预测：按地区

  • 主要区域趋势
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 欧洲其他地区
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 亚太地区其他地区
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 拉丁美洲其他地区
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋
    • MEA 的其余部分

第 9 章：公司简介

  • BIOTRONIK
  • ZOLL Medical Corporation (Asahi Kasei Group)
  • Boston Scientific Corporation
  • Abbott
  • Medtronic
  • Liva Nova
  • Schiller AG
  • Koninklijke Philips N.V.,
  • ABIOMED
  • Defibtech, LLC
  • Shree Pacetronix Ltd.
  • Osypka Medical
  • MicroPort Scientific Corporation
  • Medico S.R.L.
  • Vitatron
  • Stryker Corporation
  • CU Medical Systems Co. Ltd
  • Nihon Kohden Corporation
  • BPL Medical Technologies Pvt Ltd
  • AMI Italia
简介目录
Product Code: 3933

Cardiac Rhythm Management Devices Market share is predicted to grow at a CAGR of over 6.2% between 2023 and 2032, driven by the aging global. The demand for cardiac rhythm management devices, such as pacemakers and implantable cardioverter-defibrillators (ICDs), rises to address age-related cardiac issues. For instance, as per CDC, in 2021, approximately 695,000 people in the United States died from heart disease-that is 1 in every 5 deaths.

Continuous R&D efforts have led to the introduction of more sophisticated and effective devices, enhancing patient outcomes and encouraging the adoption of these devices by healthcare providers. The integration of smart technologies, remote monitoring capabilities, and miniaturization of devices will further contribute to the industry's outlook.

The overall cardiac rhythm management devices industry is divided based on product, application, end-use & region.

External defibrillator segment is poised for a notable growth during 2023 and 2032, owing to its crucial role in addressing sudden cardiac arrests. With growing awareness regarding the importance of timely intervention in life-threatening situations, external defibrillators are becoming more accessible and user-friendly. The widespread use of these devices in public facilities, coupled with initiatives promoting CPR and defibrillator training, is empowering both healthcare professionals and laypersons.

As per end-use scope, cardiac care centers segment will generate notable revenues for the market during 2023-2032, backed by comprehensive diagnostic and treatment services. The expertise and advanced medical technologies available in these centers provide effective and specialized care, encouraging the incorporation of cardiac rhythm management devices as essential elements in treatment plans. These centers often serve as hubs for medical research & innovation. Their involvement in clinical trials and the integration of cutting-edge technologies will further propel the product demand.

Asia pacific cardiac rhythm management devices market is slated to witness a significant growth rate through 2032, favored by the preference for preventive healthcare, leading to increased screenings and early detection of cardiac conditions. The region's dynamic economic development results in a rise in healthcare awareness, contributing to an increased willingness among individuals to invest in advanced cardiac care technologies. The ongoing expansion of healthcare infrastructure will continue to shape the market dynamics in the APAC region in the coming years.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Industry coverage
  • 1.2 Market scope & definitions
  • 1.3 Base estimates & working
    • 1.3.1 Data collection
  • 1.4 Forecast parameters
  • 1.5 COVID-19 impact at global level
  • 1.6 Data validation
  • 1.7 Data sources
    • 1.7.1 Primary
    • 1.7.2 Secondary
      • 1.7.2.1 Paid sources
      • 1.7.2.2 Unpaid sources

Chapter 2 Executive Summary

  • 2.1 Cardiac rhythm management devices industry 360 degree synopsis, 2018 - 2032
  • 2.2 Business trends
  • 2.3 Regional trends
  • 2.4 Product trends
  • 2.5 Application trends
  • 2.6 End-use

Chapter 3 Cardiac Rhythm Management Devices Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Growing prevalence of heart failure and other cardiac disorders
      • 3.2.1.2 Technological advancements and introduction of innovative devices for cardiac rhythm monitoring
      • 3.2.1.3 Increasing public awareness
      • 3.2.1.4 Rising sedentary lifestyle
      • 3.2.1.5 Favorable reimbursement scenario
      • 3.2.1.6 Growing geriatric population base coupled with rising prevalence of obesity
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 High cost of devices
      • 3.2.2.2 Product recalls
      • 3.2.2.3 Stringent regulatory approvals
  • 3.3 Growth potential analysis
    • 3.3.1 By product
    • 3.3.2 By application
    • 3.3.3 By end-use
  • 3.4 COVID-19 impact analysis
  • 3.5 Regulatory landscape
    • 3.5.1 U.S.
    • 3.5.2 Europe
  • 3.6 Reimbursement scenario
  • 3.7 Technology landscape
  • 3.8 Future market trends
  • 3.9 Pricing analysis, 2022
  • 3.10 Pipeline products
  • 3.11 Indication landscape
  • 3.12 Startup scenario
  • 3.13 Number of pacemaker units, 2018 -2032
  • 3.14 Number of Defibrillators units, 2018 -2032
  • 3.15 Number of CRT devices units, 2018 -2032
  • 3.16 Porter's analysis
  • 3.17 GAP analysis
  • 3.18 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

  • 4.1 Introduction
  • 4.2 Company matrix analysis, 2022
  • 4.3 Company market share analysis, 2022
  • 4.4 Competitive positioning matrix
  • 4.5 Vendor matrix analysis
  • 4.6 Strategy dashboard, 2022

Chapter 5 Cardiac Rhythm Management Devices Market Size and Forecast, By Product (USD Million)

  • 5.1 Key technology trends
  • 5.2 Pacemakers
    • 5.2.1 Implantable pacemakers
    • 5.2.2 External pacemakers
  • 5.3 Defibrillators
    • 5.3.1 Implantable cardioverter defibrillator (ICDs)
      • 5.3.1.1 Transvenous implantable cardioverter defibrillator
        • 5.3.1.1.1 Single-chamber ICDs
        • 5.3.1.1.2 Dual-chamber ICDs
    • 5.3.2 External Defibrillator
      • 5.3.2.1 Manual external defibrillator
      • 5.3.2.2 Automated external defibrillator
        • 5.3.2.2.1 Semi-automated external defibrillator
        • 5.3.2.2.2 Fully automated external defibrillator
      • 5.3.2.3 Wearable cardioverter defibrillator
  • 5.4 Cardiac Resynchronization Therapy Devices
    • 5.4.1 Cardiac resynchronization therapy devices- D
    • 5.4.2 Cardiac resynchronization therapy devices- P

Chapter 6 Cardiac Rhythm Management Devices Market Size and Forecast, By Application (USD Million)

  • 6.1 Key application trends
  • 6.2 Congestive heart failure
  • 6.3 Arrhythmias
  • 6.4 Bradycardia
  • 6.5 Tachycardia
  • 6.6 Others

Chapter 7 Cardiac Rhythm Management Devices Market Size and Forecast, By End-use (USD Million)

  • 7.1 Key end-use trends
  • 7.2 Hospitals
  • 7.3 Cardiac care centers
  • 7.4 Ambulatory surgical centers
  • 7.5 Others

Chapter 8 Cardiac Rhythm Management Devices Market Size and Forecast, By Region (USD Million)

  • 8.1 Key regional trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Spain
    • 8.3.5 Italy
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 South Korea
    • 8.4.5 Australia
    • 8.4.6 Rest of Asia Pacific
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Argentina
    • 8.5.4 Rest of Latin America
  • 8.6 Middle East & Africa
    • 8.6.1 South Africa
    • 8.6.2 Saudi Arabia
    • 8.6.3 UAE
    • 8.6.4 Rest of MEA

Chapter 9 Company Profiles

  • 9.1 BIOTRONIK
  • 9.2 ZOLL Medical Corporation (Asahi Kasei Group)
  • 9.3 Boston Scientific Corporation
  • 9.4 Abbott
  • 9.5 Medtronic
  • 9.6 Liva Nova
  • 9.7 Schiller AG
  • 9.8 Koninklijke Philips N.V.,
  • 9.9 ABIOMED
  • 9.10 Defibtech, LLC
  • 9.11 Shree Pacetronix Ltd.
  • 9.12 Osypka Medical
  • 9.13 MicroPort Scientific Corporation
  • 9.14 Medico S.R.L.
  • 9.15 Vitatron
  • 9.16 Stryker Corporation
  • 9.17 CU Medical Systems Co. Ltd
  • 9.18 Nihon Kohden Corporation
  • 9.19 BPL Medical Technologies Pvt Ltd
  • 9.20 AMI Italia